Swiss Re (SREN) PT Set at CHF 99.10 by Barclays

Swiss Re (VTX:SREN) has been given a CHF 99.10 price objective by research analysts at Barclays in a research note issued on Monday. The brokerage presently has a “buy” rating on the stock. Barclays’ target price points to a potential upside of 2.04% from the company’s current price.

Several other equities analysts have also weighed in on SREN. Deutsche Bank set a CHF 98 price objective on shares of Swiss Re and gave the company a “neutral” rating in a report on Monday, October 22nd. Credit Suisse Group set a CHF 99 price objective on shares of Swiss Re and gave the company a “buy” rating in a report on Wednesday, October 24th. Royal Bank of Canada set a CHF 99 price objective on shares of Swiss Re and gave the company a “neutral” rating in a report on Thursday, July 12th. Jefferies Financial Group set a CHF 87 price objective on shares of Swiss Re and gave the company a “neutral” rating in a report on Wednesday, August 8th. Finally, JPMorgan Chase & Co. set a CHF 120 price objective on shares of Swiss Re and gave the company a “buy” rating in a report on Friday, October 19th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and ten have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of CHF 99.12.

Shares of VTX SREN opened at CHF 97.12 on Monday. Swiss Re has a 1-year low of CHF 81.65 and a 1-year high of CHF 98.80.

Swiss Re Company Profile

Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.

Featured Article: Marijuana Stocks

Analyst Recommendations for Swiss Re (VTX:SREN)

Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply